Q2 2018 Holdings
Filed 2018-08-14 | 119 holdings | $3.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BioTime, Inc. | *W EXP 10/1/201 | 09066L162 | $1 | 20,084 | 0.0% |
| Cyclacel Pharmaceuticals, Inc. | PFD CONV EX 6% | 23254L207 | $89 | 13,253 | 0.0% |
| Akari Therapeutics, Plc | SPONSORED ADR | 00972G108 | $115 | 58,770 | 0.0% |
| Molecular Templates, Inc. | COM | 608550109 | $379 | 72,412 | 0.0% |
| Fulgent Genetics, Inc.(FLGT) | COM | 359664109 | $518 | 125,000 | 0.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | COM | 09060J106 | $620 | 210,021 | 0.0% |
| Affimed N.V. | COM | N01045108 | $660 | 400,000 | 0.0% |
| Stemline Therapeutics, Inc. | COM | 85858C107 | $715 | 44,524 | 0.0% |
| Ritter Pharmaceuticals, Inc. | COM NEW | 767836307 | $720 | 279,999 | 0.0% |
| Proteon Therapeutics, Inc. | COM | 74371L109 | $732 | 298,591 | 0.0% |
| Jounce Therapeutics, Inc.(JNCEEUR) | COM | 481116101 | $766 | 100,000 | 0.0% |
| T2 Biosystems, Inc. | COM | 89853L104 | $774 | 100,000 | 0.0% |
| Infinity Pharmaceuticals, Inc.(INFIQ) | COM | 45665G303 | $1.1K | 580,400 | 0.0% |
| Dynavax Technologies Corporation(DVAX) | COM NEW | 268158201 | $1.1K | 75,000 | 0.0% |
| Sunesis Pharmaceuticals, Inc. | COM PAR | 867328700 | $1.2K | 556,665 | 0.0% |
| Selecta Biosciences, Inc.(SELBUSD) | COM | 816212104 | $1.2K | 93,750 | 0.0% |
| Corbus Pharmaceuticals Holdings, Inc.(CRBPEUR) | COM | 21833P103 | $1.3K | 247,450 | 0.0% |
| Trevena, Inc. | COM | 89532E109 | $1.4K | 950,000 | 0.0% |
| MediWound Ltd. | ORD SHS | M68830104 | $1.6K | 226,000 | 0.0% |
| Ra Pharmaceuticals, Inc. | COM | 74933V108 | $1.8K | 177,952 | 0.0% |
| Ovid Therapeutics Inc.(OVID) | COM | 690469101 | $1.9K | 247,733 | 0.0% |
| NewLink Genetics Corporation | COM | 651511107 | $2.4K | 507,273 | 0.0% |
| Rigel Pharmaceuticals, Inc.(RIGLUSD) | COM NEW | 766559603 | $2.9K | 1,041,612 | 0.0% |
| Krystal Biotech, Inc.(KRYS) | COM | 501147102 | $3.0K | 200,000 | 0.0% |
| Trillium Therapeutics Inc. | COM NEW | 89620X506 | $3.1K | 511,763 | 0.0% |
| Tonix Pharmaceuticals Holdings Corp. | COM | 890260409 | $3.1K | 699,500 | 0.0% |
| Nabriva Therapeutics plc | SHS | G63637105 | $3.3K | 938,235 | 0.0% |
| Tetraphase Pharmaceuticals, Inc. | COM | 88165N105 | $3.3K | 935,000 | 0.0% |
| Forty Seven, Inc.(FTSVEUR) | COM | 34983P104 | $4.0K | 250,000 | 0.0% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $4.1K | 60,155 | 0.0% |
| Alkermes plc(ALKS) | SHS | G01767105 | $4.1K | 100,251 | 0.0% |
| Natera, Inc.(NTRA) | COM | 632307104 | $4.3K | 228,676 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | COM | 03753U106 | $4.3K | 196,078 | 0.0% |
| Spring Bank Pharmaceuticals, Inc. | COM | 849431101 | $4.4K | 373,144 | 0.0% |
| Adamas Pharmaceuticals, Inc.(ADMSEUR) | COM | 00548A106 | $4.5K | 172,630 | 0.0% |
| MacroGenics, Inc.(MGNX) | COM | 556099109 | $4.5K | 217,695 | 0.0% |
| Aevi Genomic Medicine, Inc.(GNMXEUR) | COM | 00835P105 | $4.5K | 4,055,142 | 0.0% |
| La Jolla Pharmaceutical Company(LJPC) | COM PAR $.0001 2 | 503459604 | $4.5K | 154,675 | 0.0% |
| GlycoMimetics, Inc.(GLYCEUR) | COM | 38000Q102 | $4.7K | 291,214 | 0.0% |
| Versartis, Inc. | COM | 92529L102 | $4.9K | 2,426,310 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $5.0K | 173,100 | 0.0% |
| Sesen Bio, Inc. | COM | 817763105 | $5.1K | 2,624,412 | 0.0% |
| AnaptysBio, Inc.(ANAB) | COM | 032724106 | $5.2K | 73,086 | 0.0% |
| ChemoCentryx, Inc.(CCXIEUR) | COM | 16383L106 | $5.5K | 414,029 | 0.0% |
| Achillion Pharmaceuticals, Inc.(ACHNEUR) | COM | 00448Q201 | $5.5K | 1,943,620 | 0.0% |
| Menlo Therapeutics Inc. | COM | 586858102 | $5.7K | 700,000 | 0.0% |
| Assembly Biosciences, Inc. | COM | 045396108 | $5.8K | 148,587 | 0.0% |
| Syros Pharmaceuticals, Inc. | COM | 87184Q107 | $5.9K | 574,835 | 0.0% |
| Vanda Pharmaceuticals Inc.(VNDA) | COM | 921659108 | $5.9K | 310,354 | 0.0% |
| Aegerion Pharmaceuticals, Inc. | NOTE 2% 8/15/2019 | 00767EAB8 | $6.0K | $9,517,000 | 0.0% |